Iovance Biotherapeutics Inc (IOVA)
Stock-Based Compensation
$11.73M
Quarterly · Period ending: · USD
IOVA Stock-Based Compensation
Latest reported$11.73Mperiod ending
Latest reported$11.73Mperiod ending
IOVA Quarterly Stock-Based Comp ($0.00 → $11.73M)
Quarterly stock-based compensation
High-resolution chart · PNG
IOVA stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 11,733,000 | |
| 11,269,000 | |
| 11,817,000 | |
| 11,900,000 | |
| 14,943,000 | |
| 22,915,000 | |
| 30,977,000 | |
| 31,006,000 | |
| 30,466,000 | |
| 17,178,000 | |
| 14,399,000 | |
| 15,821,000 | |
| 16,740,000 | |
| 15,665,000 | |
| 19,509,000 | |
| 19,780,000 | |
| 22,468,000 | |
| 22,265,000 | |
| 19,104,000 | |
| 19,306,000 | |
| 14,414,000 | |
| 16,941,000 | |
| 0 | |
| 10,706,000 | |
| 10,537,000 | |
| 0 | |
| 0 | |
| 6,598,000 | |
| 6,426,000 | |
| 5,846,000 | |
| 5,185,000 | |
| 5,516,000 | |
| 5,222,000 | |
| 4,104,000 | |
| 2,760,000 | |
| 2,619,000 | |
| 3,293,000 | |
| 3,296,000 | |
| 3,123,000 | |
| 8,645,000 | |
| 1,923,000 | |
| 1,779,000 | |
| 2,672,000 | |
| 2,387,000 | |
| 1,923,000 | |
| 1,467,000 | |
| 1,092,000 | |
| 940,000 | |
| 879,678 | |
| 167,057 | |
| 17,320,128 | |
| 2,459,063 | |
| 133,000 | |
| 87,386 | |
| 920,884 | |
| 697,671 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |